Exact Mass: 435.20456240000004
Exact Mass Matches: 435.20456240000004
Found 119 metabolites which its exact mass value is equals to given mass value 435.20456240000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Vertine
C26H29NO5 (435.20456240000004)
A quinolizidine alkaloid isolated from the flowering plant Heimia salicifolia and exhibits anti-inflammatory properties.
Trimazosin hydrochloride
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Melemeleone B
C23H33NO5S (435.2079328000001)
A sesquiterpenoid with a quinone and taurine functionality. It is isolated from the sponge Dysidea avara, and exhibits inhibitory activity against tyrosine kinase.
(1RS,2RS,2aRS,10aSR)-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3H-cyclobuta[4,5]pyrano[3,2-c]quinolin-3-one|ARQ500206|euodenine A
C26H29NO5 (435.20456240000004)
Ala Ala Phe Gln
Ala Ala Gln Phe
Ala Phe Ala Gln
Ala Phe Gln Ala
Ala Gln Ala Phe
Ala Gln Phe Ala
Asp Lys Ser Ser
C16H29N5O9 (435.19651840000006)
Asp Ser Lys Ser
C16H29N5O9 (435.19651840000006)
Asp Ser Ser Lys
C16H29N5O9 (435.19651840000006)
Phe Ala Ala Gln
Phe Ala Gln Ala
Phe Gly Asn Val
Phe Gly Val Asn
Phe Asn Gly Val
Phe Asn Val Gly
Phe Gln Ala Ala
Phe Val Gly Asn
Phe Val Asn Gly
Gly Phe Asn Val
Gly Phe Val Asn
Gly Asn Phe Val
Gly Asn Val Phe
Gly Val Phe Asn
Gly Val Asn Phe
Lys Asp Ser Ser
C16H29N5O9 (435.19651840000006)
Lys Ser Asp Ser
C16H29N5O9 (435.19651840000006)
Lys Ser Ser Asp
C16H29N5O9 (435.19651840000006)
Asn Phe Gly Val
Asn Phe Val Gly
Asn Gly Phe Val
Asn Gly Val Phe
Asn Thr Thr Thr
C16H29N5O9 (435.19651840000006)
Asn Val Phe Gly
Asn Val Gly Phe
Gln Ala Ala Phe
Gln Ala Phe Ala
Gln Phe Ala Ala
Gln Ser Thr Thr
C16H29N5O9 (435.19651840000006)
Gln Thr Ser Thr
C16H29N5O9 (435.19651840000006)
Gln Thr Thr Ser
C16H29N5O9 (435.19651840000006)
Arg Ser Ser Ser
Ser Asp Lys Ser
C16H29N5O9 (435.19651840000006)
Ser Asp Ser Lys
C16H29N5O9 (435.19651840000006)
Ser Lys Asp Ser
C16H29N5O9 (435.19651840000006)
Ser Lys Ser Asp
C16H29N5O9 (435.19651840000006)
Ser Gln Thr Thr
C16H29N5O9 (435.19651840000006)
Ser Arg Ser Ser
Ser Ser Asp Lys
C16H29N5O9 (435.19651840000006)
Ser Ser Lys Asp
C16H29N5O9 (435.19651840000006)
Ser Ser Arg Ser
Ser Ser Ser Arg
Ser Thr Gln Thr
C16H29N5O9 (435.19651840000006)
Ser Thr Thr Gln
C16H29N5O9 (435.19651840000006)
Thr Asn Thr Thr
C16H29N5O9 (435.19651840000006)
Thr Gln Ser Thr
C16H29N5O9 (435.19651840000006)
Thr Gln Thr Ser
C16H29N5O9 (435.19651840000006)
Thr Ser Gln Thr
C16H29N5O9 (435.19651840000006)
Thr Ser Thr Gln
C16H29N5O9 (435.19651840000006)
Thr Thr Asn Thr
C16H29N5O9 (435.19651840000006)
Thr Thr Gln Ser
C16H29N5O9 (435.19651840000006)
Thr Thr Ser Gln
C16H29N5O9 (435.19651840000006)
Thr Thr Thr Asn
C16H29N5O9 (435.19651840000006)
Val Phe Gly Asn
Val Phe Asn Gly
Val Gly Phe Asn
Val Gly Asn Phe
Val Asn Phe Gly
Val Asn Gly Phe
CAY10585
C26H29NO5 (435.20456240000004)
LW6 (HIF-1α inhibitor) is a novel HIF-1 inhibitor with an IC50 of 4.4 μM. LW6 decreases HIF-1α protein expression without affecting HIF-1β expression.
Thieno[2,3-b]quinoline-2-carboxamide, N-cyclopentyl-N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl- (9CI)
C25H29N3O2S (435.19803740000003)
4-NITROPHENYL PHOSPHATE DI(CYCLOHEXYLAMINE) SALT MONOHYDRATE
4-Nitrophenyl phosphate,bis(cyclohexylammonium) salt hydrate
2,4-Diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
2,4-Diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
TRIMAZOSIN
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
[4-(Phenylmethyl)piperidin-1-Yl]-[1-(5-Pyrrol-1-Yl-1,3,4-Thiadiazol-2-Yl)piperidin-4-Yl]methanone
C24H29N5OS (435.20927040000004)
6-methoxy-3-[[[1-(2-methoxyethyl)-5-tetrazolyl]methyl-(3-pyridinylmethyl)amino]methyl]-1H-quinolin-2-one
C22H25N7O3 (435.20187799999997)
Methyl 3-{2-[4-(adamantan-2-YL)phenoxy]acetamido}-4-hydroxybenzoate
C26H29NO5 (435.20456240000004)
[1-[3-(4-Chlorophenoxy)propyl]-4-piperidinyl]-diphenylmethanol
(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
9-hydroxy-4,5-dimethoxy-16-oxa-23-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁸,²³]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
(1s,13e,17r,19r)-9-hydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
3-methoxy-6-{2-[2-methyl-5-(prop-1-en-2-yl)oxolan-2-yl]ethenyl}-4-phenyl-3h-quinoline-2,4,5-triol
C26H29NO5 (435.20456240000004)
2,4-dimethyl-4-[2-(2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl)ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(2r,4s)-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(2e,6e)-8-[4,6-dihydroxy-1-oxo-2-(2-phenylethyl)-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid
C26H29NO5 (435.20456240000004)
8-[4,6-dihydroxy-1-oxo-2-(2-phenylethyl)-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid
C26H29NO5 (435.20456240000004)
(1s,13z,17s,19s)-9-hydroxy-5,6-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2,4,6,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
2-[(5-{[(1r,2s,4as,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]ethanesulfonic acid
C23H33NO5S (435.2079328000001)
9-hydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(2s,4r)-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(3s,4s)-3-methoxy-6-[(1e)-2-[(2r,5r)-2-methyl-5-(prop-1-en-2-yl)oxolan-2-yl]ethenyl]-4-phenyl-3h-quinoline-2,4,5-triol
C26H29NO5 (435.20456240000004)